Inactief instrument

Koers Intercell AG

Aandelen

Duur

Periode

Stijl

VIVALIS : et Intercell fusionnent pour former Valneva	17-12-12
Intercell AG : La biotech française Vivalis rachète l'autrichienne Intercell	17-12-12
Intercell AG : Annual Report 2011	16-04-12
Intercell AG : Intercell and Statens Serum Institut (SSI) progress vaccine clinical development to fight Tuberculosis	11-01-12
Intercell AG : Thomas Szucs elected new chairman of Intercell’s Supervisory Board	30-12-11

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-4,66%	86,13 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 mld.
BIOGEN INC.	-19,27%	30,42 mld.
UCB	+57,86%	25,23 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,36 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 mld.
INCYTE CORPORATION	-17,69%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 mld.
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 mld.